Evidence map›Paper›PMID 35547141›Full record

ArticleFrontiers in microbiology2022

Diletta Collalto, Giulia Giallonardi, Alessandra Fortuna, Carlo Meneghini, Ersilia Fiscarelli, Paolo Visca, Francesco Imperi, Giordano Rampioni, Livia Leoni

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  5. Quorum Sensing and its Inhibition inCurrent drug targets · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. A bacterial pigment provides cross-species protection from HProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Review
  11. Review
  12. Alkyl-quinolone-dependent quorum sensing controls prophage-mediated autolysis inFrontiers in cellular and infection microbiology · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Diletta CollaltoDepartment of Science, Roma Tre University, Rome, Italy.
Giulia GiallonardiDepartment of Science, Roma Tre University, Rome, Italy.
Alessandra FortunaDepartment of Science, Roma Tre University, Rome, Italy.
Carlo MeneghiniDepartment of Science, Roma Tre University, Rome, Italy.
Ersilia FiscarelliLaboratory of Cystic Fibrosis Microbiology, Diagnostic Medicine and Laboratory, Bambino Gesú Hospital, Rome, Italy.
Paolo ViscaDepartment of Science, Roma Tre University, Rome, Italy.
Francesco ImperiDepartment of Science, Roma Tre University, Rome, Italy.
Giordano RampioniDepartment of Science, Roma Tre University, Rome, Italy.
Livia LeoniDepartment of Science, Roma Tre University, Rome, Italy.
Roma Tre University · ITBambino Gesù Children's Hospital · ITFondazione Santa Lucia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chronic lung infection caused by

Indexed as

antivirulence drugsclofoctolcystic fibrosisniclosamidePseudomonas aeruginosaquorum quenchingquorum sensing

Identifiers

PMID35547141
PMCPMC9083110
OpenAlexW4224797221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.